Article mayhem
   
Nav Menu
select
home
select
Sign up
select
Login
select
Submit Articles
select
Submission Guidelines
select
Top Articles
select
Link Directory
select
About Us
select
Contact Us
select
Privacy Policy
select
RSS Feeds
 
Categories

Accessories
Arts
Business
Cars and Trucks
CGI
Coding Sites
Computers
Cooking
Crafts
Current Affairs
Databases
Entertainment
Film
Finances
Gardening
Healthy Living
Holidays
Home
Internet
Medical
Men Only
Motorcyles
Our Pets
Outdoors
Relationships
Religion
Self Improvement
Sports
Staying Fit
Technology
Travel
Web Design
Weddings
Women Only
Writing
 
Stats
Total Articles: 519629
Total Authors: 142199
Total Downloads: 20359322


Newest Member
Patrick Winter

 


   

How the HIF-1 beta antibody aids vascular research


The Hypoxia Inducible Factors are a family of dimeric transcriptional regulators which play an important role in oxidative homeostasis during hypoxic conditions. HIF-1 is composed of alpha and beta subunits, represented by HIF-1 alpha and HIF-1 beta antibody products, both of which are well represented on our antibody database.

HIF-1 is an oxygen-sensitive complex, essential to hypoxic regulation during embryonic vascular development. In humans, the HIF-1 alpha subunit is encoded by the HIF1A gene, whereas the HIF-1 beta subunit is encoded by the ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) gene.

In normoxic conditions, the two subunits are dissociated. HIF-1 beta is located in the nucleus, and HIF-1 alpha in the cytoplasm, where it is rapidly degraded following HIF prolyl-hydroxylase activation. During hypoxia, HIF prolyl-hydroxylase is inhibited, leading to an increase in HIF-1 alpha levels. The alpha subunit then translocates to the nucleus, forming a stable HIF-1 dimer with the HIF-1 beta subunit.

Recent HIF-1 research has indicated HIF-1 stabilisation during hypoxia promotes mRNA stabilization and upregulation of a number of genes, including vascular endothelial growth factor (VEGF). This protein protects the growing embryo during periods of inadequate oxygen delivery, by promoting angiogenesis. However, the HIF-1 complex is also activated during solid tumour formation, owing to increased oxygen demand.

Currently, the HIF-1 beta antibody is one of the products being used to investigate induction of the HIF-1 complex in normoxic cells. It has been shown that chronic inflammatory conditions may cause aberrant functioning of transcription factors such as HIF-1, resulting in altered expression of chemokines, growth factor etc. This in turn may provide ideal “growing conditions” for metastasis and cancer.



Author Resource:- The Article is written by www.novusbio.com providing Antibody and Antibodies. Visit http://www.novusbio.com for more information on www.novusbio.com Products and Services___________________________Copyright information This article is free for reproduction but must be reproduced in its entirety, including live links and this copyright statement must be included. Visit www.novusbio.com for more services!

[Valid RSS feed]  Category Rss Feed - http://www.articlemayhem.com/rss.php?rss=191
By : Gen Federico    29 or more times read
Submitted 2011-08-29 07:39:52
Article From Article Mayhem

ezine ready view Ezine ready view

Related Articles

 
 


[Valid RSS feed]